|
Tuesday 12th July 2022 |
Text too small? |
CellCo is an agricultural company working on cellular agriculture. It specialises in development of alternative proteins. CellCo was formed in 2022, and is classified as seed stage, with its technology origins being from University of Auckland.
BIF has made an initial cash investment of $125,000. Following this transaction (and issue of additional units to fund the purchase), Cell Co will represent 1.3% of BIF’s investment portfolio of 24 companies, and with a net asset value of over $9.6m.
Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz
BIF - Acquires shares in CellCo
No comments yet
Devon Funds Morning Note - 04 May 2026
MEL - Meridian joins global ranks of sustainable companies
May 5th Morning Report
ATM - a2MC recalls small volume of a2 Platinum USA label
CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update